Robert T. Schimke (1932–2014): Architect of Genomic Plasticity
Robert T. Schimke was a titan of 20th-century molecular biology whose work fundamentally reshaped our understanding of how cells regulate their internal machinery. At a time when the genome was viewed as a static "blueprint," Schimke’s research revealed it to be a dynamic, adaptable landscape. His discovery of gene amplification provided a cornerstone for modern cancer research and the multibillion-dollar biotechnology industry.
1. Biography: From the Pacific Northwest to Stanford
Robert Tod Schimke was born on October 25, 1932, in Spokane, Washington. A gifted student, he moved south to Stanford University, where he would spend nearly his entire academic life. He earned his A.B. in 1954 and his M.D. in 1958.
Rather than pursuing clinical practice, Schimke was drawn to the mechanisms of life at the molecular level. After completing his residency at Massachusetts General Hospital, he joined the National Institutes of Health (NIH) in 1960. There, he worked in the laboratory of Christian Anfinsen (who would later win the Nobel Prize), focusing on how enzymes are regulated in the liver.
In 1966, Schimke returned to Stanford as an Associate Professor in the Department of Pharmacology. He eventually moved to the Department of Biological Sciences, where he served as chair for two separate terms (1970–1973 and 1978–1982). He remained at Stanford until his retirement, continuing to influence the field even after a debilitating stroke in 1995 shifted his focus from the pipette to the paintbrush.
2. Major Contributions: Overturning Biological Dogma
Schimke’s career is defined by two revolutionary insights that challenged the scientific status quo.
The Dynamics of Protein Turnover
In the early 1960s, the prevailing view was that once a protein was synthesized in a cell, it remained there until the cell died or divided. Schimke proved this wrong. He demonstrated that the concentration of an enzyme is not just a result of how fast it is made, but also how fast it is destroyed. He established the concept of protein turnover, showing that intracellular proteins are in a constant state of flux. This "steady-state" theory explained how cells could rapidly change their enzymatic makeup in response to hormones or diet.
The Discovery of Gene Amplification
Schimke’s most famous contribution came in the late 1970s. He was investigating why cancer cells often become resistant to methotrexate, a common chemotherapy drug. Methotrexate works by inhibiting an enzyme called dihydrofolate reductase (DHFR).
Schimke and his team discovered that resistant cells weren't just mutating the enzyme; they were creating extra copies of the gene that produced it. By "amplifying" the DHFR gene, the cell could produce so much enzyme that the drug was overwhelmed. This discovery shattered the dogma that the amount of DNA in a cell’s genome was fixed and unchangeable during a lifetime. It proved that the genome could expand and contract in response to environmental pressure.
3. Notable Publications
Schimke was a prolific author with hundreds of papers to his name. His most influential works include:
- "The roles of synthesis and degradation in the control of enzyme levels in mammalian systems" (1969, Science): A foundational paper that articulated his findings on protein turnover.
- "Amplification of dihydrofolate reductase genes in methotrexate-resistant cultured mouse cells" (1978, Journal of Biological Chemistry): Co-authored with Fred Alt and others, this landmark study detailed the mechanism of gene amplification.
- "Gene amplification in mammalian cells" (1984, Cell): A comprehensive review that synthesized how genomic instability leads to gene duplication, providing a roadmap for future cancer research.
4. Awards & Recognition
Schimke’s contributions earned him a place among the elite of American science:
- National Academy of Sciences (1976): Elected at the relatively young age of 43.
- American Academy of Arts and Sciences: Elected member.
- Alfred P. Sloan, Jr. Prize (1982): Awarded by the General Motors Cancer Research Foundation for his work on drug resistance.
- Gairdner Foundation International Award (1985): Often a precursor to the Nobel Prize, recognizing his discovery of gene amplification.
- The Commonwealth Fund Award: For his contributions to medical research.
5. Impact & Legacy
Schimke’s legacy is visible in two primary fields:
Oncology
The discovery of gene amplification explained one of the greatest hurdles in cancer treatment: acquired drug resistance. It also led to the discovery of oncogenes (like HER2 in breast cancer) that are amplified in tumors, driving their growth. Modern "targeted" therapies are a direct descendant of the understanding of gene dosage that Schimke pioneered.
Biotechnology
The biotech industry relies on Schimke’s work to produce life-saving drugs. To manufacture large quantities of proteins like insulin, erythropoietin (EPO), or monoclonal antibodies, scientists use "Chinese Hamster Ovary" (CHO) cells. By applying Schimke’s methods of gene amplification, they force these cells to carry hundreds of copies of a specific gene, turning the cells into high-output "factories" for medicine.
6. Collaborations
Schimke was known for fostering a high-energy, collaborative environment. Notable colleagues and trainees include:
- Fred Alt: A student of Schimke who went on to become a leading geneticist at Harvard, Alt was instrumental in the initial gene amplification experiments.
- Rodney Kellems: Another key collaborator in the DHFR research.
- Christian Anfinsen: His early mentor at the NIH, who instilled in him the rigors of biochemical analysis.
Schimke’s lab at Stanford was a "Who’s Who" of molecular biology, producing dozens of professors and researchers who now lead departments across the globe.
7. Lesser-Known Facts
- The "Artist’s Second Act": In 1995, Schimke suffered a severe stroke that left him with aphasia (difficulty speaking) and paralyzed his right side. Forced to retire from science, he taught himself to paint with his left hand. He became a prolific and celebrated digital and acrylic artist, producing thousands of works that were exhibited in galleries. He viewed his art as a new way to explore the complexity of patterns, much like his work in biology.
- Avid Cyclist: Before his stroke, Schimke was a legendary figure on the Stanford campus, often seen commuting on his bicycle. He was known for his physical stamina, which many colleagues said mirrored his intellectual persistence.
- A "Scientific Rebel": When he first proposed that genes could be duplicated within a cell's lifespan, he faced significant skepticism. The idea of "genomic plasticity" was seen by some as borderline heretical to the Central Dogma of biology, yet he persisted until the evidence was undeniable.
Robert T. Schimke passed away on September 6, 2014, at the age of 81. He remains a pivotal figure in the history of biology—a man who looked at the "fixed" code of life and saw a vibrant, changing system.